✉news TechnologyTechnology first seen 3 d ago, last 3 d ago, peak #26
FDA unveils new framework for rare disease regulation
Original: Rare disease regulation reaches “inflection point” with new FDA framework
The FDA has introduced a new regulatory framework for rare disease treatments, which industry observers describe as reaching an 'inflection point' in how such therapies are developed and approved. The change is expected to affect drug developers, patient groups and regulators working in the rare disease field, though details of the framework's provisions and its practical impact have not yet been widely reported.
Why now: The FDA's new framework signals a potentially major shift in rare disease drug regulation, drawing attention from pharma companies and patient advocates.
Rank over time, top of the chart is #1. 2 snapshots from 3 d ago to 3 d ago.
Evidence
- Rare disease regulation reaches “inflection point” with new FDA framework · Pharmaceutical Technology
API: https://socialmediatrends-api.osmike.com/v1/trends/2355266